Patient_ID
stringlengths 8
8
| Age
int64 18
89
| Gender
stringclasses 2
values | Weight_kg
float64 50.2
100
| Height_cm
float64 150
200
| Comorbidities
stringclasses 4
values | Previous_Treatments
stringclasses 3
values | Tumor_Histology
stringclasses 4
values | Tumor_Grade
stringclasses 3
values | Tumor_Stage
stringclasses 4
values | Imaging_Modality
stringclasses 3
values | Image_Resolution
stringclasses 2
values | Scan_Type
stringclasses 2
values | Scanner_Manufacturer
stringclasses 3
values | Gross_Tumor_Volume_cm3
float64 1.22
150
| Clinical_Target_Volume_cm3
float64 0.96
200
| Planning_Target_Volume_cm3
float64 1.47
249
| Beam_Arrangements
stringclasses 2
values | Dose_Distributions_Gy
float64 10.2
99.8
| Optimization_Objectives
stringclasses 3
values | Dose_Volume_Histogram
stringlengths 9
9
| Synthetic_Image_Path
stringlengths 41
41
| GTV_Segmentation_Path
stringlengths 45
45
| CTV_Segmentation_Path
stringlengths 45
45
| PTV_Segmentation_Path
stringlengths 45
45
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SIM-0001 | 36 | Male | 67.6 | 155.7 | Hypertension | Surgery | Meningioma | Low | III | PET | Isotropic | Contrast-Enhanced | Siemens | 148.73 | 29.01 | 143.24 | Single | 35.04 | Maximize Tumor Dose | DVH_P0001 | /simulated/path/P0001_synthetic_image.nii | /simulated/path/SIM-0001_GTV_segmentation.nii | /simulated/path/SIM-0001_CTV_segmentation.nii | /simulated/path/SIM-0001_PTV_segmentation.nii |
SIM-0002 | 20 | Female | 62.7 | 178.3 | Hypertension | Radiotherapy | Glioblastoma | Intermediate | II | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 72.72 | 74.71 | 212.1 | Single | 91.26 | Balanced | DVH_P0002 | /simulated/path/P0002_synthetic_image.nii | /simulated/path/SIM-0002_GTV_segmentation.nii | /simulated/path/SIM-0002_CTV_segmentation.nii | /simulated/path/SIM-0002_PTV_segmentation.nii |
SIM-0003 | 65 | Female | 74.6 | 171 | Hypertension | null | Metastatic | High | III | PET | Anisotropic | Contrast-Enhanced | Siemens | 111.56 | 167.26 | 153.63 | Single | 70.64 | Maximize Tumor Dose | DVH_P0003 | /simulated/path/P0003_synthetic_image.nii | /simulated/path/SIM-0003_GTV_segmentation.nii | /simulated/path/SIM-0003_CTV_segmentation.nii | /simulated/path/SIM-0003_PTV_segmentation.nii |
SIM-0004 | 57 | Female | 90 | 187.5 | null | Surgery | Astrocytoma | Intermediate | III | PET | Anisotropic | Contrast-Enhanced | Philips | 115.48 | 143.11 | 11.71 | Single | 84.85 | Organ-Sparing | DVH_P0004 | /simulated/path/P0004_synthetic_image.nii | /simulated/path/SIM-0004_GTV_segmentation.nii | /simulated/path/SIM-0004_CTV_segmentation.nii | /simulated/path/SIM-0004_PTV_segmentation.nii |
SIM-0005 | 86 | Female | 91.3 | 165.8 | Cardiac Issues | null | Glioblastoma | Low | II | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 47.73 | 14.87 | 78.38 | Multi-Beam | 45.22 | Organ-Sparing | DVH_P0005 | /simulated/path/P0005_synthetic_image.nii | /simulated/path/SIM-0005_GTV_segmentation.nii | /simulated/path/SIM-0005_CTV_segmentation.nii | /simulated/path/SIM-0005_PTV_segmentation.nii |
SIM-0006 | 80 | Female | 73.5 | 152.7 | Hypertension | Radiotherapy | Astrocytoma | Intermediate | II | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 110.17 | 68.01 | 43.6 | Multi-Beam | 74.06 | Balanced | DVH_P0006 | /simulated/path/P0006_synthetic_image.nii | /simulated/path/SIM-0006_GTV_segmentation.nii | /simulated/path/SIM-0006_CTV_segmentation.nii | /simulated/path/SIM-0006_PTV_segmentation.nii |
SIM-0007 | 61 | Female | 66.3 | 172.9 | null | Chemotherapy | Meningioma | High | IV | CT | Isotropic | Non-Contrast-Enhanced | Philips | 31.25 | 189.54 | 44.62 | Multi-Beam | 97.29 | Maximize Tumor Dose | DVH_P0007 | /simulated/path/P0007_synthetic_image.nii | /simulated/path/SIM-0007_GTV_segmentation.nii | /simulated/path/SIM-0007_CTV_segmentation.nii | /simulated/path/SIM-0007_PTV_segmentation.nii |
SIM-0008 | 50 | Female | 94.9 | 195.7 | Diabetes | Chemotherapy | Astrocytoma | High | I | CT | Isotropic | Non-Contrast-Enhanced | Philips | 56.38 | 197.43 | 234.48 | Single | 45.66 | Maximize Tumor Dose | DVH_P0008 | /simulated/path/P0008_synthetic_image.nii | /simulated/path/SIM-0008_GTV_segmentation.nii | /simulated/path/SIM-0008_CTV_segmentation.nii | /simulated/path/SIM-0008_PTV_segmentation.nii |
SIM-0009 | 84 | Female | 58 | 184.8 | Cardiac Issues | Radiotherapy | Metastatic | Intermediate | I | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 117.83 | 56.97 | 245.46 | Multi-Beam | 68.41 | Maximize Tumor Dose | DVH_P0009 | /simulated/path/P0009_synthetic_image.nii | /simulated/path/SIM-0009_GTV_segmentation.nii | /simulated/path/SIM-0009_CTV_segmentation.nii | /simulated/path/SIM-0009_PTV_segmentation.nii |
SIM-0010 | 28 | Male | 93.8 | 192.9 | Hypertension | Chemotherapy | Metastatic | Low | IV | CT | Isotropic | Contrast-Enhanced | Siemens | 135.13 | 101.51 | 142.62 | Single | 60.7 | Balanced | DVH_P0010 | /simulated/path/P0010_synthetic_image.nii | /simulated/path/SIM-0010_GTV_segmentation.nii | /simulated/path/SIM-0010_CTV_segmentation.nii | /simulated/path/SIM-0010_PTV_segmentation.nii |
SIM-0011 | 87 | Female | 55.8 | 182.8 | Cancer History | Chemotherapy | Meningioma | Intermediate | IV | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 73.37 | 118.87 | 7.26 | Single | 90.98 | Maximize Tumor Dose | DVH_P0011 | /simulated/path/P0011_synthetic_image.nii | /simulated/path/SIM-0011_GTV_segmentation.nii | /simulated/path/SIM-0011_CTV_segmentation.nii | /simulated/path/SIM-0011_PTV_segmentation.nii |
SIM-0012 | 83 | Male | 80.1 | 169.5 | Hypertension | Surgery | Glioblastoma | Intermediate | III | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 144.12 | 162.91 | 190.12 | Single | 54.94 | Organ-Sparing | DVH_P0012 | /simulated/path/P0012_synthetic_image.nii | /simulated/path/SIM-0012_GTV_segmentation.nii | /simulated/path/SIM-0012_CTV_segmentation.nii | /simulated/path/SIM-0012_PTV_segmentation.nii |
SIM-0013 | 64 | Male | 92.1 | 172.1 | Cancer History | Surgery | Glioblastoma | Low | IV | CT | Anisotropic | Contrast-Enhanced | Siemens | 78.47 | 55.83 | 221.58 | Single | 81.78 | Organ-Sparing | DVH_P0013 | /simulated/path/P0013_synthetic_image.nii | /simulated/path/SIM-0013_GTV_segmentation.nii | /simulated/path/SIM-0013_CTV_segmentation.nii | /simulated/path/SIM-0013_PTV_segmentation.nii |
SIM-0014 | 88 | Female | 88.9 | 162.9 | Diabetes | Radiotherapy | Metastatic | High | II | CT | Isotropic | Contrast-Enhanced | GE | 15.93 | 131.69 | 236.14 | Multi-Beam | 76.93 | Balanced | DVH_P0014 | /simulated/path/P0014_synthetic_image.nii | /simulated/path/SIM-0014_GTV_segmentation.nii | /simulated/path/SIM-0014_CTV_segmentation.nii | /simulated/path/SIM-0014_PTV_segmentation.nii |
SIM-0015 | 86 | Female | 69.1 | 180.7 | Hypertension | Chemotherapy | Glioblastoma | Intermediate | IV | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 10.75 | 28.74 | 204.99 | Multi-Beam | 66.99 | Balanced | DVH_P0015 | /simulated/path/P0015_synthetic_image.nii | /simulated/path/SIM-0015_GTV_segmentation.nii | /simulated/path/SIM-0015_CTV_segmentation.nii | /simulated/path/SIM-0015_PTV_segmentation.nii |
SIM-0016 | 21 | Female | 63.7 | 160.5 | null | Chemotherapy | Metastatic | Intermediate | II | CT | Isotropic | Non-Contrast-Enhanced | GE | 21.62 | 63.02 | 152.55 | Single | 66.62 | Balanced | DVH_P0016 | /simulated/path/P0016_synthetic_image.nii | /simulated/path/SIM-0016_GTV_segmentation.nii | /simulated/path/SIM-0016_CTV_segmentation.nii | /simulated/path/SIM-0016_PTV_segmentation.nii |
SIM-0017 | 71 | Female | 50.8 | 178.2 | null | Chemotherapy | Meningioma | Intermediate | IV | MRI | Isotropic | Contrast-Enhanced | GE | 144.99 | 15.16 | 133.71 | Single | 57.55 | Organ-Sparing | DVH_P0017 | /simulated/path/P0017_synthetic_image.nii | /simulated/path/SIM-0017_GTV_segmentation.nii | /simulated/path/SIM-0017_CTV_segmentation.nii | /simulated/path/SIM-0017_PTV_segmentation.nii |
SIM-0018 | 47 | Male | 60.3 | 177.6 | Cancer History | Surgery | Astrocytoma | Intermediate | III | CT | Isotropic | Contrast-Enhanced | Philips | 43.59 | 113.7 | 115.86 | Multi-Beam | 39.81 | Maximize Tumor Dose | DVH_P0018 | /simulated/path/P0018_synthetic_image.nii | /simulated/path/SIM-0018_GTV_segmentation.nii | /simulated/path/SIM-0018_CTV_segmentation.nii | /simulated/path/SIM-0018_PTV_segmentation.nii |
SIM-0019 | 33 | Male | 96.3 | 155.2 | Hypertension | Chemotherapy | Astrocytoma | Intermediate | III | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 18.91 | 82.48 | 201.4 | Multi-Beam | 81.72 | Organ-Sparing | DVH_P0019 | /simulated/path/P0019_synthetic_image.nii | /simulated/path/SIM-0019_GTV_segmentation.nii | /simulated/path/SIM-0019_CTV_segmentation.nii | /simulated/path/SIM-0019_PTV_segmentation.nii |
SIM-0020 | 78 | Female | 83.4 | 160.7 | Diabetes | Chemotherapy | Metastatic | Intermediate | II | CT | Isotropic | Contrast-Enhanced | GE | 83.96 | 87.85 | 151.66 | Multi-Beam | 55.09 | Organ-Sparing | DVH_P0020 | /simulated/path/P0020_synthetic_image.nii | /simulated/path/SIM-0020_GTV_segmentation.nii | /simulated/path/SIM-0020_CTV_segmentation.nii | /simulated/path/SIM-0020_PTV_segmentation.nii |
SIM-0021 | 35 | Male | 60 | 188.2 | Hypertension | Chemotherapy | Meningioma | Intermediate | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 3.65 | 95.52 | 118.49 | Multi-Beam | 57.21 | Organ-Sparing | DVH_P0021 | /simulated/path/P0021_synthetic_image.nii | /simulated/path/SIM-0021_GTV_segmentation.nii | /simulated/path/SIM-0021_CTV_segmentation.nii | /simulated/path/SIM-0021_PTV_segmentation.nii |
SIM-0022 | 60 | Male | 57.8 | 152.3 | Diabetes | Chemotherapy | Meningioma | High | I | MRI | Isotropic | Contrast-Enhanced | GE | 119.27 | 39.03 | 92.61 | Single | 36.59 | Maximize Tumor Dose | DVH_P0022 | /simulated/path/P0022_synthetic_image.nii | /simulated/path/SIM-0022_GTV_segmentation.nii | /simulated/path/SIM-0022_CTV_segmentation.nii | /simulated/path/SIM-0022_PTV_segmentation.nii |
SIM-0023 | 35 | Female | 56.9 | 167.2 | Hypertension | null | Glioblastoma | High | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 106.77 | 199.58 | 13.77 | Single | 75.2 | Maximize Tumor Dose | DVH_P0023 | /simulated/path/P0023_synthetic_image.nii | /simulated/path/SIM-0023_GTV_segmentation.nii | /simulated/path/SIM-0023_CTV_segmentation.nii | /simulated/path/SIM-0023_PTV_segmentation.nii |
SIM-0024 | 19 | Female | 63 | 179.6 | Cardiac Issues | null | Astrocytoma | Intermediate | I | PET | Isotropic | Contrast-Enhanced | Philips | 60.05 | 58.19 | 239.7 | Multi-Beam | 43.22 | Maximize Tumor Dose | DVH_P0024 | /simulated/path/P0024_synthetic_image.nii | /simulated/path/SIM-0024_GTV_segmentation.nii | /simulated/path/SIM-0024_CTV_segmentation.nii | /simulated/path/SIM-0024_PTV_segmentation.nii |
SIM-0025 | 68 | Female | 68.2 | 192.2 | null | null | Astrocytoma | Low | II | CT | Isotropic | Non-Contrast-Enhanced | Philips | 50.99 | 163.47 | 150.16 | Single | 60.55 | Maximize Tumor Dose | DVH_P0025 | /simulated/path/P0025_synthetic_image.nii | /simulated/path/SIM-0025_GTV_segmentation.nii | /simulated/path/SIM-0025_CTV_segmentation.nii | /simulated/path/SIM-0025_PTV_segmentation.nii |
SIM-0026 | 23 | Male | 95.5 | 172.7 | null | Radiotherapy | Astrocytoma | Low | I | PET | Anisotropic | Contrast-Enhanced | Siemens | 75.93 | 49.45 | 187.4 | Multi-Beam | 37.78 | Balanced | DVH_P0026 | /simulated/path/P0026_synthetic_image.nii | /simulated/path/SIM-0026_GTV_segmentation.nii | /simulated/path/SIM-0026_CTV_segmentation.nii | /simulated/path/SIM-0026_PTV_segmentation.nii |
SIM-0027 | 44 | Male | 78.7 | 176.1 | Hypertension | Chemotherapy | Astrocytoma | Intermediate | II | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 73.26 | 85.4 | 9.29 | Single | 29.45 | Organ-Sparing | DVH_P0027 | /simulated/path/P0027_synthetic_image.nii | /simulated/path/SIM-0027_GTV_segmentation.nii | /simulated/path/SIM-0027_CTV_segmentation.nii | /simulated/path/SIM-0027_PTV_segmentation.nii |
SIM-0028 | 31 | Male | 86.5 | 163.9 | Cancer History | Surgery | Glioblastoma | Low | IV | PET | Isotropic | Contrast-Enhanced | Siemens | 83.68 | 105.61 | 244.9 | Single | 94.59 | Maximize Tumor Dose | DVH_P0028 | /simulated/path/P0028_synthetic_image.nii | /simulated/path/SIM-0028_GTV_segmentation.nii | /simulated/path/SIM-0028_CTV_segmentation.nii | /simulated/path/SIM-0028_PTV_segmentation.nii |
SIM-0029 | 49 | Female | 77 | 160.1 | Hypertension | null | Meningioma | High | IV | CT | Anisotropic | Contrast-Enhanced | Philips | 63.73 | 107.81 | 94.39 | Single | 41.72 | Balanced | DVH_P0029 | /simulated/path/P0029_synthetic_image.nii | /simulated/path/SIM-0029_GTV_segmentation.nii | /simulated/path/SIM-0029_CTV_segmentation.nii | /simulated/path/SIM-0029_PTV_segmentation.nii |
SIM-0030 | 68 | Female | 61.9 | 187.3 | Cardiac Issues | Chemotherapy | Meningioma | Low | I | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 33.95 | 143.26 | 220.76 | Single | 56.67 | Organ-Sparing | DVH_P0030 | /simulated/path/P0030_synthetic_image.nii | /simulated/path/SIM-0030_GTV_segmentation.nii | /simulated/path/SIM-0030_CTV_segmentation.nii | /simulated/path/SIM-0030_PTV_segmentation.nii |
SIM-0031 | 35 | Male | 66.7 | 197.6 | Hypertension | null | Glioblastoma | High | IV | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 126.21 | 141.08 | 243.46 | Multi-Beam | 84.85 | Balanced | DVH_P0031 | /simulated/path/P0031_synthetic_image.nii | /simulated/path/SIM-0031_GTV_segmentation.nii | /simulated/path/SIM-0031_CTV_segmentation.nii | /simulated/path/SIM-0031_PTV_segmentation.nii |
SIM-0032 | 43 | Male | 64 | 197.2 | Cardiac Issues | Chemotherapy | Metastatic | Intermediate | IV | MRI | Anisotropic | Contrast-Enhanced | Philips | 40.67 | 5.38 | 184.47 | Multi-Beam | 27.81 | Balanced | DVH_P0032 | /simulated/path/P0032_synthetic_image.nii | /simulated/path/SIM-0032_GTV_segmentation.nii | /simulated/path/SIM-0032_CTV_segmentation.nii | /simulated/path/SIM-0032_PTV_segmentation.nii |
SIM-0033 | 27 | Female | 99.2 | 189.3 | null | null | Glioblastoma | Intermediate | IV | PET | Anisotropic | Contrast-Enhanced | GE | 76.59 | 40.94 | 95.54 | Single | 95.33 | Organ-Sparing | DVH_P0033 | /simulated/path/P0033_synthetic_image.nii | /simulated/path/SIM-0033_GTV_segmentation.nii | /simulated/path/SIM-0033_CTV_segmentation.nii | /simulated/path/SIM-0033_PTV_segmentation.nii |
SIM-0034 | 22 | Male | 92.1 | 193.1 | Cancer History | Chemotherapy | Astrocytoma | Intermediate | II | PET | Isotropic | Contrast-Enhanced | Siemens | 84.21 | 136.68 | 19.85 | Multi-Beam | 90.73 | Balanced | DVH_P0034 | /simulated/path/P0034_synthetic_image.nii | /simulated/path/SIM-0034_GTV_segmentation.nii | /simulated/path/SIM-0034_CTV_segmentation.nii | /simulated/path/SIM-0034_PTV_segmentation.nii |
SIM-0035 | 20 | Female | 68.2 | 181.9 | Cancer History | Surgery | Metastatic | High | III | MRI | Anisotropic | Contrast-Enhanced | Philips | 52.73 | 26.8 | 187.41 | Multi-Beam | 10.15 | Maximize Tumor Dose | DVH_P0035 | /simulated/path/P0035_synthetic_image.nii | /simulated/path/SIM-0035_GTV_segmentation.nii | /simulated/path/SIM-0035_CTV_segmentation.nii | /simulated/path/SIM-0035_PTV_segmentation.nii |
SIM-0036 | 29 | Male | 98.8 | 150.9 | Diabetes | Surgery | Meningioma | Intermediate | II | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 20.58 | 175.93 | 163.29 | Multi-Beam | 74.16 | Balanced | DVH_P0036 | /simulated/path/P0036_synthetic_image.nii | /simulated/path/SIM-0036_GTV_segmentation.nii | /simulated/path/SIM-0036_CTV_segmentation.nii | /simulated/path/SIM-0036_PTV_segmentation.nii |
SIM-0037 | 31 | Male | 71.8 | 165.4 | Hypertension | Surgery | Meningioma | Intermediate | II | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 77.7 | 42.44 | 65.02 | Single | 81.99 | Balanced | DVH_P0037 | /simulated/path/P0037_synthetic_image.nii | /simulated/path/SIM-0037_GTV_segmentation.nii | /simulated/path/SIM-0037_CTV_segmentation.nii | /simulated/path/SIM-0037_PTV_segmentation.nii |
SIM-0038 | 82 | Female | 52.1 | 157.5 | Cardiac Issues | Radiotherapy | Meningioma | Low | III | PET | Isotropic | Non-Contrast-Enhanced | Philips | 118.59 | 66.24 | 149.08 | Single | 53.17 | Balanced | DVH_P0038 | /simulated/path/P0038_synthetic_image.nii | /simulated/path/SIM-0038_GTV_segmentation.nii | /simulated/path/SIM-0038_CTV_segmentation.nii | /simulated/path/SIM-0038_PTV_segmentation.nii |
SIM-0039 | 54 | Male | 64.2 | 183 | Hypertension | null | Astrocytoma | High | IV | PET | Isotropic | Non-Contrast-Enhanced | Philips | 21.8 | 80.61 | 125.32 | Single | 23.05 | Balanced | DVH_P0039 | /simulated/path/P0039_synthetic_image.nii | /simulated/path/SIM-0039_GTV_segmentation.nii | /simulated/path/SIM-0039_CTV_segmentation.nii | /simulated/path/SIM-0039_PTV_segmentation.nii |
SIM-0040 | 60 | Male | 52.9 | 163.8 | Hypertension | Radiotherapy | Meningioma | Low | III | CT | Isotropic | Contrast-Enhanced | Siemens | 62.56 | 56.16 | 78.17 | Single | 49.33 | Maximize Tumor Dose | DVH_P0040 | /simulated/path/P0040_synthetic_image.nii | /simulated/path/SIM-0040_GTV_segmentation.nii | /simulated/path/SIM-0040_CTV_segmentation.nii | /simulated/path/SIM-0040_PTV_segmentation.nii |
SIM-0041 | 76 | Female | 50.8 | 169.6 | null | Surgery | Metastatic | Intermediate | III | PET | Anisotropic | Non-Contrast-Enhanced | GE | 129.85 | 36.4 | 90.28 | Multi-Beam | 29.64 | Balanced | DVH_P0041 | /simulated/path/P0041_synthetic_image.nii | /simulated/path/SIM-0041_GTV_segmentation.nii | /simulated/path/SIM-0041_CTV_segmentation.nii | /simulated/path/SIM-0041_PTV_segmentation.nii |
SIM-0042 | 70 | Female | 56.7 | 167.5 | Cancer History | Surgery | Meningioma | High | II | MRI | Anisotropic | Contrast-Enhanced | GE | 108.36 | 105.18 | 130.47 | Single | 23.94 | Maximize Tumor Dose | DVH_P0042 | /simulated/path/P0042_synthetic_image.nii | /simulated/path/SIM-0042_GTV_segmentation.nii | /simulated/path/SIM-0042_CTV_segmentation.nii | /simulated/path/SIM-0042_PTV_segmentation.nii |
SIM-0043 | 33 | Female | 99 | 162.6 | Diabetes | Radiotherapy | Metastatic | High | II | PET | Isotropic | Non-Contrast-Enhanced | GE | 139.08 | 6.3 | 100.46 | Single | 94.65 | Balanced | DVH_P0043 | /simulated/path/P0043_synthetic_image.nii | /simulated/path/SIM-0043_GTV_segmentation.nii | /simulated/path/SIM-0043_CTV_segmentation.nii | /simulated/path/SIM-0043_PTV_segmentation.nii |
SIM-0044 | 26 | Female | 63.7 | 165.7 | Diabetes | Chemotherapy | Meningioma | Low | I | MRI | Anisotropic | Non-Contrast-Enhanced | GE | 127.99 | 59.49 | 123.04 | Single | 50.13 | Maximize Tumor Dose | DVH_P0044 | /simulated/path/P0044_synthetic_image.nii | /simulated/path/SIM-0044_GTV_segmentation.nii | /simulated/path/SIM-0044_CTV_segmentation.nii | /simulated/path/SIM-0044_PTV_segmentation.nii |
SIM-0045 | 44 | Male | 84.3 | 194 | Cancer History | Surgery | Glioblastoma | Intermediate | I | CT | Anisotropic | Contrast-Enhanced | Philips | 46.37 | 96.28 | 90.87 | Single | 57.6 | Maximize Tumor Dose | DVH_P0045 | /simulated/path/P0045_synthetic_image.nii | /simulated/path/SIM-0045_GTV_segmentation.nii | /simulated/path/SIM-0045_CTV_segmentation.nii | /simulated/path/SIM-0045_PTV_segmentation.nii |
SIM-0046 | 74 | Male | 93.9 | 190.9 | Diabetes | Surgery | Metastatic | Intermediate | III | CT | Isotropic | Non-Contrast-Enhanced | Philips | 67.18 | 124.81 | 44.23 | Multi-Beam | 35.15 | Balanced | DVH_P0046 | /simulated/path/P0046_synthetic_image.nii | /simulated/path/SIM-0046_GTV_segmentation.nii | /simulated/path/SIM-0046_CTV_segmentation.nii | /simulated/path/SIM-0046_PTV_segmentation.nii |
SIM-0047 | 69 | Female | 99 | 176.2 | Cancer History | null | Astrocytoma | Low | I | PET | Anisotropic | Contrast-Enhanced | GE | 66.22 | 95.13 | 29.16 | Multi-Beam | 34.8 | Balanced | DVH_P0047 | /simulated/path/P0047_synthetic_image.nii | /simulated/path/SIM-0047_GTV_segmentation.nii | /simulated/path/SIM-0047_CTV_segmentation.nii | /simulated/path/SIM-0047_PTV_segmentation.nii |
SIM-0048 | 76 | Male | 73.2 | 159.7 | Cardiac Issues | null | Astrocytoma | Low | II | MRI | Anisotropic | Contrast-Enhanced | Siemens | 146.54 | 53.66 | 188.28 | Multi-Beam | 51.56 | Organ-Sparing | DVH_P0048 | /simulated/path/P0048_synthetic_image.nii | /simulated/path/SIM-0048_GTV_segmentation.nii | /simulated/path/SIM-0048_CTV_segmentation.nii | /simulated/path/SIM-0048_PTV_segmentation.nii |
SIM-0049 | 19 | Female | 63.6 | 166.4 | Cancer History | null | Astrocytoma | Low | II | PET | Isotropic | Contrast-Enhanced | Philips | 132.27 | 184.09 | 37.52 | Single | 87.31 | Organ-Sparing | DVH_P0049 | /simulated/path/P0049_synthetic_image.nii | /simulated/path/SIM-0049_GTV_segmentation.nii | /simulated/path/SIM-0049_CTV_segmentation.nii | /simulated/path/SIM-0049_PTV_segmentation.nii |
SIM-0050 | 84 | Male | 91.5 | 178.9 | Cardiac Issues | Radiotherapy | Meningioma | Low | II | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 135.28 | 177.82 | 4.78 | Single | 63.92 | Balanced | DVH_P0050 | /simulated/path/P0050_synthetic_image.nii | /simulated/path/SIM-0050_GTV_segmentation.nii | /simulated/path/SIM-0050_CTV_segmentation.nii | /simulated/path/SIM-0050_PTV_segmentation.nii |
SIM-0051 | 77 | Male | 59.1 | 174 | Cancer History | Chemotherapy | Meningioma | Low | II | CT | Isotropic | Non-Contrast-Enhanced | Philips | 135.19 | 68.54 | 40.06 | Multi-Beam | 71.74 | Organ-Sparing | DVH_P0051 | /simulated/path/P0051_synthetic_image.nii | /simulated/path/SIM-0051_GTV_segmentation.nii | /simulated/path/SIM-0051_CTV_segmentation.nii | /simulated/path/SIM-0051_PTV_segmentation.nii |
SIM-0052 | 88 | Female | 55.5 | 198.1 | null | Radiotherapy | Astrocytoma | Intermediate | III | MRI | Anisotropic | Contrast-Enhanced | Siemens | 34.02 | 60.67 | 125.88 | Single | 22.88 | Organ-Sparing | DVH_P0052 | /simulated/path/P0052_synthetic_image.nii | /simulated/path/SIM-0052_GTV_segmentation.nii | /simulated/path/SIM-0052_CTV_segmentation.nii | /simulated/path/SIM-0052_PTV_segmentation.nii |
SIM-0053 | 89 | Female | 98.2 | 188.8 | Cancer History | null | Glioblastoma | High | III | PET | Anisotropic | Non-Contrast-Enhanced | Siemens | 52.94 | 28.25 | 14.13 | Single | 92.06 | Balanced | DVH_P0053 | /simulated/path/P0053_synthetic_image.nii | /simulated/path/SIM-0053_GTV_segmentation.nii | /simulated/path/SIM-0053_CTV_segmentation.nii | /simulated/path/SIM-0053_PTV_segmentation.nii |
SIM-0054 | 73 | Female | 81.1 | 173 | null | Surgery | Metastatic | High | III | CT | Isotropic | Contrast-Enhanced | Philips | 83.35 | 106.21 | 184.49 | Single | 11.64 | Maximize Tumor Dose | DVH_P0054 | /simulated/path/P0054_synthetic_image.nii | /simulated/path/SIM-0054_GTV_segmentation.nii | /simulated/path/SIM-0054_CTV_segmentation.nii | /simulated/path/SIM-0054_PTV_segmentation.nii |
SIM-0055 | 28 | Female | 70.3 | 195 | Cancer History | Radiotherapy | Meningioma | Low | I | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 116.77 | 125.71 | 192.23 | Multi-Beam | 31.99 | Balanced | DVH_P0055 | /simulated/path/P0055_synthetic_image.nii | /simulated/path/SIM-0055_GTV_segmentation.nii | /simulated/path/SIM-0055_CTV_segmentation.nii | /simulated/path/SIM-0055_PTV_segmentation.nii |
SIM-0056 | 18 | Male | 98 | 158.7 | null | Radiotherapy | Glioblastoma | High | III | PET | Anisotropic | Contrast-Enhanced | Siemens | 132.09 | 40.16 | 141.99 | Single | 79.51 | Balanced | DVH_P0056 | /simulated/path/P0056_synthetic_image.nii | /simulated/path/SIM-0056_GTV_segmentation.nii | /simulated/path/SIM-0056_CTV_segmentation.nii | /simulated/path/SIM-0056_PTV_segmentation.nii |
SIM-0057 | 38 | Female | 87 | 172.2 | Cardiac Issues | null | Metastatic | High | I | CT | Isotropic | Non-Contrast-Enhanced | GE | 20.23 | 185.05 | 208.51 | Single | 44.55 | Balanced | DVH_P0057 | /simulated/path/P0057_synthetic_image.nii | /simulated/path/SIM-0057_GTV_segmentation.nii | /simulated/path/SIM-0057_CTV_segmentation.nii | /simulated/path/SIM-0057_PTV_segmentation.nii |
SIM-0058 | 35 | Male | 85.6 | 169.3 | Hypertension | Surgery | Metastatic | Intermediate | IV | CT | Anisotropic | Contrast-Enhanced | Philips | 55.63 | 43.07 | 147.32 | Single | 79.82 | Organ-Sparing | DVH_P0058 | /simulated/path/P0058_synthetic_image.nii | /simulated/path/SIM-0058_GTV_segmentation.nii | /simulated/path/SIM-0058_CTV_segmentation.nii | /simulated/path/SIM-0058_PTV_segmentation.nii |
SIM-0059 | 39 | Female | 70.9 | 197.2 | Hypertension | null | Metastatic | Intermediate | II | CT | Isotropic | Contrast-Enhanced | Philips | 70.56 | 149.6 | 5.76 | Multi-Beam | 96.46 | Organ-Sparing | DVH_P0059 | /simulated/path/P0059_synthetic_image.nii | /simulated/path/SIM-0059_GTV_segmentation.nii | /simulated/path/SIM-0059_CTV_segmentation.nii | /simulated/path/SIM-0059_PTV_segmentation.nii |
SIM-0060 | 55 | Male | 78.5 | 159.5 | null | null | Glioblastoma | Low | II | MRI | Isotropic | Contrast-Enhanced | GE | 81.38 | 157.76 | 7.77 | Single | 77.81 | Organ-Sparing | DVH_P0060 | /simulated/path/P0060_synthetic_image.nii | /simulated/path/SIM-0060_GTV_segmentation.nii | /simulated/path/SIM-0060_CTV_segmentation.nii | /simulated/path/SIM-0060_PTV_segmentation.nii |
SIM-0061 | 33 | Male | 94.7 | 187.1 | Cardiac Issues | null | Glioblastoma | High | I | CT | Anisotropic | Non-Contrast-Enhanced | GE | 133.71 | 157.2 | 140.91 | Multi-Beam | 76.95 | Organ-Sparing | DVH_P0061 | /simulated/path/P0061_synthetic_image.nii | /simulated/path/SIM-0061_GTV_segmentation.nii | /simulated/path/SIM-0061_CTV_segmentation.nii | /simulated/path/SIM-0061_PTV_segmentation.nii |
SIM-0062 | 67 | Female | 62.1 | 170.1 | Hypertension | Radiotherapy | Astrocytoma | Intermediate | III | CT | Isotropic | Contrast-Enhanced | GE | 140.39 | 183.89 | 6.34 | Single | 94.89 | Balanced | DVH_P0062 | /simulated/path/P0062_synthetic_image.nii | /simulated/path/SIM-0062_GTV_segmentation.nii | /simulated/path/SIM-0062_CTV_segmentation.nii | /simulated/path/SIM-0062_PTV_segmentation.nii |
SIM-0063 | 32 | Female | 80.1 | 196.1 | null | null | Astrocytoma | High | II | PET | Anisotropic | Contrast-Enhanced | Siemens | 75.61 | 105.58 | 232.89 | Single | 38.73 | Organ-Sparing | DVH_P0063 | /simulated/path/P0063_synthetic_image.nii | /simulated/path/SIM-0063_GTV_segmentation.nii | /simulated/path/SIM-0063_CTV_segmentation.nii | /simulated/path/SIM-0063_PTV_segmentation.nii |
SIM-0064 | 23 | Female | 89.9 | 190 | Cancer History | Surgery | Meningioma | Intermediate | I | CT | Anisotropic | Contrast-Enhanced | GE | 85.25 | 127.48 | 186.6 | Multi-Beam | 34.62 | Maximize Tumor Dose | DVH_P0064 | /simulated/path/P0064_synthetic_image.nii | /simulated/path/SIM-0064_GTV_segmentation.nii | /simulated/path/SIM-0064_CTV_segmentation.nii | /simulated/path/SIM-0064_PTV_segmentation.nii |
SIM-0065 | 40 | Female | 87.8 | 152.6 | null | Surgery | Astrocytoma | Intermediate | II | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 92.33 | 26.39 | 154.98 | Multi-Beam | 95.44 | Balanced | DVH_P0065 | /simulated/path/P0065_synthetic_image.nii | /simulated/path/SIM-0065_GTV_segmentation.nii | /simulated/path/SIM-0065_CTV_segmentation.nii | /simulated/path/SIM-0065_PTV_segmentation.nii |
SIM-0066 | 40 | Female | 70.7 | 191.9 | Hypertension | Radiotherapy | Meningioma | Intermediate | III | CT | Anisotropic | Contrast-Enhanced | Philips | 2.2 | 159.72 | 31.51 | Multi-Beam | 10.31 | Balanced | DVH_P0066 | /simulated/path/P0066_synthetic_image.nii | /simulated/path/SIM-0066_GTV_segmentation.nii | /simulated/path/SIM-0066_CTV_segmentation.nii | /simulated/path/SIM-0066_PTV_segmentation.nii |
SIM-0067 | 89 | Male | 84.5 | 188.3 | Hypertension | Chemotherapy | Meningioma | High | III | MRI | Isotropic | Contrast-Enhanced | Siemens | 143.83 | 137.42 | 137.21 | Multi-Beam | 85.42 | Maximize Tumor Dose | DVH_P0067 | /simulated/path/P0067_synthetic_image.nii | /simulated/path/SIM-0067_GTV_segmentation.nii | /simulated/path/SIM-0067_CTV_segmentation.nii | /simulated/path/SIM-0067_PTV_segmentation.nii |
SIM-0068 | 81 | Male | 76.2 | 153.8 | Diabetes | Surgery | Astrocytoma | Intermediate | IV | MRI | Anisotropic | Contrast-Enhanced | Siemens | 45.64 | 69.44 | 103.65 | Single | 16.97 | Organ-Sparing | DVH_P0068 | /simulated/path/P0068_synthetic_image.nii | /simulated/path/SIM-0068_GTV_segmentation.nii | /simulated/path/SIM-0068_CTV_segmentation.nii | /simulated/path/SIM-0068_PTV_segmentation.nii |
SIM-0069 | 65 | Male | 59.5 | 166.8 | Diabetes | Surgery | Metastatic | Low | II | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 60.52 | 63.15 | 68.99 | Single | 15.51 | Maximize Tumor Dose | DVH_P0069 | /simulated/path/P0069_synthetic_image.nii | /simulated/path/SIM-0069_GTV_segmentation.nii | /simulated/path/SIM-0069_CTV_segmentation.nii | /simulated/path/SIM-0069_PTV_segmentation.nii |
SIM-0070 | 89 | Female | 73.5 | 188.7 | Cardiac Issues | null | Glioblastoma | Low | I | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 92.67 | 89.49 | 217.57 | Single | 36.47 | Organ-Sparing | DVH_P0070 | /simulated/path/P0070_synthetic_image.nii | /simulated/path/SIM-0070_GTV_segmentation.nii | /simulated/path/SIM-0070_CTV_segmentation.nii | /simulated/path/SIM-0070_PTV_segmentation.nii |
SIM-0071 | 58 | Male | 59.3 | 150.4 | Diabetes | Surgery | Glioblastoma | High | IV | MRI | Isotropic | Contrast-Enhanced | Philips | 82.03 | 24.07 | 181.84 | Single | 75.56 | Maximize Tumor Dose | DVH_P0071 | /simulated/path/P0071_synthetic_image.nii | /simulated/path/SIM-0071_GTV_segmentation.nii | /simulated/path/SIM-0071_CTV_segmentation.nii | /simulated/path/SIM-0071_PTV_segmentation.nii |
SIM-0072 | 65 | Female | 87.6 | 192.1 | Hypertension | null | Glioblastoma | Intermediate | IV | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 49.39 | 182.64 | 44.52 | Single | 43.3 | Maximize Tumor Dose | DVH_P0072 | /simulated/path/P0072_synthetic_image.nii | /simulated/path/SIM-0072_GTV_segmentation.nii | /simulated/path/SIM-0072_CTV_segmentation.nii | /simulated/path/SIM-0072_PTV_segmentation.nii |
SIM-0073 | 41 | Female | 79.4 | 171.3 | null | Surgery | Astrocytoma | High | I | MRI | Anisotropic | Contrast-Enhanced | Siemens | 108.26 | 100.87 | 32.06 | Single | 20.78 | Balanced | DVH_P0073 | /simulated/path/P0073_synthetic_image.nii | /simulated/path/SIM-0073_GTV_segmentation.nii | /simulated/path/SIM-0073_CTV_segmentation.nii | /simulated/path/SIM-0073_PTV_segmentation.nii |
SIM-0074 | 18 | Male | 92.8 | 197 | Diabetes | Surgery | Glioblastoma | High | I | CT | Isotropic | Contrast-Enhanced | Siemens | 117.47 | 32.95 | 223.19 | Multi-Beam | 37.62 | Organ-Sparing | DVH_P0074 | /simulated/path/P0074_synthetic_image.nii | /simulated/path/SIM-0074_GTV_segmentation.nii | /simulated/path/SIM-0074_CTV_segmentation.nii | /simulated/path/SIM-0074_PTV_segmentation.nii |
SIM-0075 | 55 | Male | 56.3 | 198.1 | Hypertension | Surgery | Metastatic | High | III | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 32.34 | 45.99 | 152.73 | Single | 58.59 | Organ-Sparing | DVH_P0075 | /simulated/path/P0075_synthetic_image.nii | /simulated/path/SIM-0075_GTV_segmentation.nii | /simulated/path/SIM-0075_CTV_segmentation.nii | /simulated/path/SIM-0075_PTV_segmentation.nii |
SIM-0076 | 20 | Male | 83.3 | 168.9 | Hypertension | null | Meningioma | Intermediate | III | CT | Isotropic | Contrast-Enhanced | Siemens | 78.95 | 138.23 | 103.12 | Single | 48.03 | Organ-Sparing | DVH_P0076 | /simulated/path/P0076_synthetic_image.nii | /simulated/path/SIM-0076_GTV_segmentation.nii | /simulated/path/SIM-0076_CTV_segmentation.nii | /simulated/path/SIM-0076_PTV_segmentation.nii |
SIM-0077 | 67 | Male | 76.1 | 187.5 | Cardiac Issues | Radiotherapy | Astrocytoma | Low | I | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 25.19 | 187.18 | 162.9 | Multi-Beam | 91.95 | Organ-Sparing | DVH_P0077 | /simulated/path/P0077_synthetic_image.nii | /simulated/path/SIM-0077_GTV_segmentation.nii | /simulated/path/SIM-0077_CTV_segmentation.nii | /simulated/path/SIM-0077_PTV_segmentation.nii |
SIM-0078 | 53 | Female | 92.8 | 153.3 | Hypertension | Chemotherapy | Metastatic | High | IV | MRI | Isotropic | Contrast-Enhanced | Philips | 133.13 | 135.98 | 146.62 | Multi-Beam | 11.43 | Balanced | DVH_P0078 | /simulated/path/P0078_synthetic_image.nii | /simulated/path/SIM-0078_GTV_segmentation.nii | /simulated/path/SIM-0078_CTV_segmentation.nii | /simulated/path/SIM-0078_PTV_segmentation.nii |
SIM-0079 | 20 | Female | 80.2 | 155 | null | Surgery | Glioblastoma | Intermediate | I | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 142.68 | 146.66 | 20.08 | Single | 11.93 | Maximize Tumor Dose | DVH_P0079 | /simulated/path/P0079_synthetic_image.nii | /simulated/path/SIM-0079_GTV_segmentation.nii | /simulated/path/SIM-0079_CTV_segmentation.nii | /simulated/path/SIM-0079_PTV_segmentation.nii |
SIM-0080 | 67 | Female | 96.5 | 174.4 | Diabetes | Surgery | Astrocytoma | High | III | CT | Isotropic | Contrast-Enhanced | Philips | 100.93 | 172.39 | 170.37 | Single | 51.22 | Balanced | DVH_P0080 | /simulated/path/P0080_synthetic_image.nii | /simulated/path/SIM-0080_GTV_segmentation.nii | /simulated/path/SIM-0080_CTV_segmentation.nii | /simulated/path/SIM-0080_PTV_segmentation.nii |
SIM-0081 | 18 | Male | 59.2 | 158.8 | null | Chemotherapy | Meningioma | Intermediate | II | CT | Isotropic | Non-Contrast-Enhanced | GE | 5.57 | 141.21 | 25.8 | Multi-Beam | 18.11 | Maximize Tumor Dose | DVH_P0081 | /simulated/path/P0081_synthetic_image.nii | /simulated/path/SIM-0081_GTV_segmentation.nii | /simulated/path/SIM-0081_CTV_segmentation.nii | /simulated/path/SIM-0081_PTV_segmentation.nii |
SIM-0082 | 74 | Male | 61.5 | 166.4 | Cancer History | Surgery | Meningioma | High | IV | PET | Isotropic | Contrast-Enhanced | Siemens | 87.57 | 82.4 | 49.67 | Single | 27.82 | Maximize Tumor Dose | DVH_P0082 | /simulated/path/P0082_synthetic_image.nii | /simulated/path/SIM-0082_GTV_segmentation.nii | /simulated/path/SIM-0082_CTV_segmentation.nii | /simulated/path/SIM-0082_PTV_segmentation.nii |
SIM-0083 | 43 | Female | 82.1 | 176.4 | Diabetes | null | Metastatic | Intermediate | IV | CT | Isotropic | Contrast-Enhanced | Philips | 49.5 | 20.27 | 11.02 | Multi-Beam | 61.11 | Organ-Sparing | DVH_P0083 | /simulated/path/P0083_synthetic_image.nii | /simulated/path/SIM-0083_GTV_segmentation.nii | /simulated/path/SIM-0083_CTV_segmentation.nii | /simulated/path/SIM-0083_PTV_segmentation.nii |
SIM-0084 | 51 | Male | 56.3 | 198.2 | null | Radiotherapy | Metastatic | Intermediate | I | PET | Isotropic | Contrast-Enhanced | GE | 39.74 | 129.25 | 226.55 | Single | 66.46 | Balanced | DVH_P0084 | /simulated/path/P0084_synthetic_image.nii | /simulated/path/SIM-0084_GTV_segmentation.nii | /simulated/path/SIM-0084_CTV_segmentation.nii | /simulated/path/SIM-0084_PTV_segmentation.nii |
SIM-0085 | 59 | Female | 92.7 | 172.2 | Diabetes | Radiotherapy | Glioblastoma | Low | IV | CT | Anisotropic | Non-Contrast-Enhanced | GE | 16.08 | 98.36 | 104.41 | Single | 51.51 | Maximize Tumor Dose | DVH_P0085 | /simulated/path/P0085_synthetic_image.nii | /simulated/path/SIM-0085_GTV_segmentation.nii | /simulated/path/SIM-0085_CTV_segmentation.nii | /simulated/path/SIM-0085_PTV_segmentation.nii |
SIM-0086 | 82 | Female | 86.1 | 162.5 | Diabetes | null | Glioblastoma | High | II | MRI | Anisotropic | Contrast-Enhanced | Philips | 149.16 | 102.93 | 55.77 | Multi-Beam | 20.16 | Balanced | DVH_P0086 | /simulated/path/P0086_synthetic_image.nii | /simulated/path/SIM-0086_GTV_segmentation.nii | /simulated/path/SIM-0086_CTV_segmentation.nii | /simulated/path/SIM-0086_PTV_segmentation.nii |
SIM-0087 | 88 | Male | 66.4 | 182.8 | Diabetes | Surgery | Metastatic | High | II | CT | Isotropic | Non-Contrast-Enhanced | Philips | 19.29 | 27.17 | 246.38 | Multi-Beam | 27.49 | Maximize Tumor Dose | DVH_P0087 | /simulated/path/P0087_synthetic_image.nii | /simulated/path/SIM-0087_GTV_segmentation.nii | /simulated/path/SIM-0087_CTV_segmentation.nii | /simulated/path/SIM-0087_PTV_segmentation.nii |
SIM-0088 | 44 | Female | 97.3 | 199.8 | Cancer History | null | Metastatic | Low | II | CT | Isotropic | Non-Contrast-Enhanced | Philips | 104.66 | 163.44 | 221.45 | Multi-Beam | 52.58 | Balanced | DVH_P0088 | /simulated/path/P0088_synthetic_image.nii | /simulated/path/SIM-0088_GTV_segmentation.nii | /simulated/path/SIM-0088_CTV_segmentation.nii | /simulated/path/SIM-0088_PTV_segmentation.nii |
SIM-0089 | 62 | Female | 95.6 | 175.9 | Diabetes | Chemotherapy | Glioblastoma | High | II | CT | Anisotropic | Contrast-Enhanced | GE | 121.92 | 79.51 | 181.99 | Single | 14.42 | Maximize Tumor Dose | DVH_P0089 | /simulated/path/P0089_synthetic_image.nii | /simulated/path/SIM-0089_GTV_segmentation.nii | /simulated/path/SIM-0089_CTV_segmentation.nii | /simulated/path/SIM-0089_PTV_segmentation.nii |
SIM-0090 | 52 | Male | 61.8 | 181 | null | Radiotherapy | Metastatic | Intermediate | II | PET | Isotropic | Non-Contrast-Enhanced | Philips | 102.11 | 128.62 | 46.73 | Single | 62.59 | Organ-Sparing | DVH_P0090 | /simulated/path/P0090_synthetic_image.nii | /simulated/path/SIM-0090_GTV_segmentation.nii | /simulated/path/SIM-0090_CTV_segmentation.nii | /simulated/path/SIM-0090_PTV_segmentation.nii |
SIM-0091 | 83 | Female | 82.7 | 180.3 | Cancer History | Surgery | Astrocytoma | Intermediate | IV | MRI | Isotropic | Contrast-Enhanced | GE | 97.2 | 183.32 | 161.93 | Multi-Beam | 65.17 | Maximize Tumor Dose | DVH_P0091 | /simulated/path/P0091_synthetic_image.nii | /simulated/path/SIM-0091_GTV_segmentation.nii | /simulated/path/SIM-0091_CTV_segmentation.nii | /simulated/path/SIM-0091_PTV_segmentation.nii |
SIM-0092 | 43 | Male | 82 | 157.5 | Cardiac Issues | Radiotherapy | Glioblastoma | Low | IV | PET | Anisotropic | Contrast-Enhanced | Philips | 38.43 | 66.57 | 47.83 | Multi-Beam | 79.09 | Organ-Sparing | DVH_P0092 | /simulated/path/P0092_synthetic_image.nii | /simulated/path/SIM-0092_GTV_segmentation.nii | /simulated/path/SIM-0092_CTV_segmentation.nii | /simulated/path/SIM-0092_PTV_segmentation.nii |
SIM-0093 | 63 | Female | 51.4 | 165.3 | null | null | Metastatic | Intermediate | IV | PET | Isotropic | Contrast-Enhanced | GE | 80.17 | 55.12 | 97.17 | Multi-Beam | 31.63 | Organ-Sparing | DVH_P0093 | /simulated/path/P0093_synthetic_image.nii | /simulated/path/SIM-0093_GTV_segmentation.nii | /simulated/path/SIM-0093_CTV_segmentation.nii | /simulated/path/SIM-0093_PTV_segmentation.nii |
SIM-0094 | 33 | Female | 55.8 | 155.2 | Hypertension | null | Glioblastoma | Low | I | PET | Isotropic | Contrast-Enhanced | Siemens | 71.57 | 165.54 | 247.41 | Multi-Beam | 44.94 | Maximize Tumor Dose | DVH_P0094 | /simulated/path/P0094_synthetic_image.nii | /simulated/path/SIM-0094_GTV_segmentation.nii | /simulated/path/SIM-0094_CTV_segmentation.nii | /simulated/path/SIM-0094_PTV_segmentation.nii |
SIM-0095 | 38 | Male | 69.9 | 192.1 | Diabetes | Radiotherapy | Meningioma | Intermediate | II | CT | Anisotropic | Non-Contrast-Enhanced | GE | 66.24 | 73.44 | 119.01 | Multi-Beam | 40.17 | Balanced | DVH_P0095 | /simulated/path/P0095_synthetic_image.nii | /simulated/path/SIM-0095_GTV_segmentation.nii | /simulated/path/SIM-0095_CTV_segmentation.nii | /simulated/path/SIM-0095_PTV_segmentation.nii |
SIM-0096 | 24 | Male | 82.4 | 166.6 | null | null | Meningioma | Intermediate | IV | MRI | Anisotropic | Non-Contrast-Enhanced | GE | 105.15 | 10.4 | 38.3 | Single | 95.66 | Organ-Sparing | DVH_P0096 | /simulated/path/P0096_synthetic_image.nii | /simulated/path/SIM-0096_GTV_segmentation.nii | /simulated/path/SIM-0096_CTV_segmentation.nii | /simulated/path/SIM-0096_PTV_segmentation.nii |
SIM-0097 | 71 | Male | 70.2 | 183.3 | Hypertension | Radiotherapy | Glioblastoma | Low | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 100.77 | 101.83 | 205.57 | Single | 86.4 | Balanced | DVH_P0097 | /simulated/path/P0097_synthetic_image.nii | /simulated/path/SIM-0097_GTV_segmentation.nii | /simulated/path/SIM-0097_CTV_segmentation.nii | /simulated/path/SIM-0097_PTV_segmentation.nii |
SIM-0098 | 80 | Female | 92.1 | 183.4 | Hypertension | Chemotherapy | Meningioma | Low | I | CT | Isotropic | Contrast-Enhanced | GE | 52.86 | 42.88 | 123.36 | Single | 48.24 | Balanced | DVH_P0098 | /simulated/path/P0098_synthetic_image.nii | /simulated/path/SIM-0098_GTV_segmentation.nii | /simulated/path/SIM-0098_CTV_segmentation.nii | /simulated/path/SIM-0098_PTV_segmentation.nii |
SIM-0099 | 26 | Female | 93.7 | 189.1 | Cardiac Issues | Surgery | Meningioma | Low | I | CT | Isotropic | Non-Contrast-Enhanced | GE | 121.08 | 165.03 | 225.62 | Single | 14.84 | Maximize Tumor Dose | DVH_P0099 | /simulated/path/P0099_synthetic_image.nii | /simulated/path/SIM-0099_GTV_segmentation.nii | /simulated/path/SIM-0099_CTV_segmentation.nii | /simulated/path/SIM-0099_PTV_segmentation.nii |
SIM-0100 | 22 | Female | 93.9 | 177.8 | Diabetes | null | Metastatic | High | IV | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 137.96 | 190.36 | 60.65 | Multi-Beam | 82.81 | Maximize Tumor Dose | DVH_P0100 | /simulated/path/P0100_synthetic_image.nii | /simulated/path/SIM-0100_GTV_segmentation.nii | /simulated/path/SIM-0100_CTV_segmentation.nii | /simulated/path/SIM-0100_PTV_segmentation.nii |